EFFECTIVENESS OF PNEUMOCOCCAL CONJUGATE VACCINE IN GREATER VANCOUVER, CANADA: 2004–2005
- 1 June 2007
- journal article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 26 (6) , 540-542
- https://doi.org/10.1097/inf.0b013e31803c56df
Abstract
Active, population-based surveillance for invasive pneumococcal infections in Greater Vancouver (population 473,000 children) demonstrated a rapid, substantial decrease in incidence rates for children 6-23 months old with routine infant vaccination. In the subpopulation with best case ascertainment disease rates for 6-23 month olds decreased 84.6% (92.5% for vaccine serotypes).Keywords
This publication has 5 references indexed in Scilit:
- Progress in the prevention of pneumococcal infectionCMAJ : Canadian Medical Association Journal, 2005
- Population-Based Impact of Pneumococcal Conjugate Vaccine in Young ChildrenPublished by American Academy of Pediatrics (AAP) ,2004
- A Pharmacoeconomic Evaluation of 7‐Valent Pneumococcal Conjugate Vaccine in CanadaClinical Infectious Diseases, 2003
- Population-based epidemiology of invasive pneumococcal infection in children in nine urban centers in Canada, 1994 through 1998The Pediatric Infectious Disease Journal, 2002
- Invasive Pneumococcal Infections in Canadian Children, 1991-1998: Implications for New Vaccination StrategiesClinical Infectious Diseases, 2000